Secondary GBM tumors, developing from a lower grade astrocytoma and generally with better prognosis than de novo (primary) GBM [13], are currently classified as grade 4 astrocytoma with mutation in the isocitrate dehydrogenase gene (IDH) (Table 1). This evidence concerns the gene IDH3A and astrocytoma (excluding glioblastoma).